Phathom Pharmaceuticals
PHAT
PHAT
114 hedge funds and large institutions have $599M invested in Phathom Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
6% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 17
2% more capital invested
Capital invested by funds: $588M → $599M (+$10.4M)
0% more funds holding
Funds holding: 114 → 114 (0)
Holders
114
Holding in Top 10
10
Calls
$5.18M
Puts
$606K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$11.4M | |
| 3 | +$5.41M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$4.68M |
| 5 |
CC
Checkpoint Capital
San Francisco,
California
|
+$4.43M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$4.83M | |
| 3 | -$2.58M | |
| 4 |
Millennium Management
New York
|
-$2.39M |
| 5 |
NM
Newtyn Management
New York
|
-$1.75M |